Meiji Yasuda Asset Management Co Ltd. Acquires Shares of 2,141 HealthEquity, Inc. (NASDAQ:HQY)

Meiji Yasuda Asset Management Co Ltd. bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, HoldingsChannel reports. The fund bought 2,141 shares of the company’s stock, valued at approximately $205,000.

A number of other hedge funds also recently modified their holdings of HQY. Wealthfront Advisers LLC acquired a new position in HealthEquity during the fourth quarter valued at approximately $10,304,089,000. Vanguard Group Inc. lifted its holdings in shares of HealthEquity by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock worth $861,256,000 after acquiring an additional 99,624 shares during the last quarter. Wasatch Advisors LP boosted its stake in shares of HealthEquity by 6.6% in the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after purchasing an additional 483,269 shares in the last quarter. State Street Corp boosted its stake in shares of HealthEquity by 0.8% in the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock valued at $256,346,000 after purchasing an additional 23,613 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of HealthEquity by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock valued at $170,197,000 after purchasing an additional 15,145 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

Shares of HQY opened at $86.96 on Friday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm’s fifty day simple moving average is $103.63 and its two-hundred day simple moving average is $95.91. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59. The stock has a market capitalization of $7.52 billion, a P/E ratio of 79.78, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.20% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Wells Fargo & Company raised their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. Royal Bank of Canada raised their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. The Goldman Sachs Group lowered their target price on HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a report on Thursday. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and cut their price target for the company from $120.00 to $115.00 in a research note on Tuesday. Finally, JMP Securities upped their price objective on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $112.23.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.